Scholastic achievement of children with lymphoma or Wilms tumor at the end of comprehensive education - A nationwide, register-based study

International Journal of Cancer

Volumn 123, Issue 10, 2008, Pages 2401-2405

  Lähteenmäki, Päivi M ^a   Sankila, Risto ^b,c   Pukkala, Eero ^b,c   Kyyrönen, Pentti ^b   Harila Saari, Arja ^d  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Child; Kidney; Late effect; Lymphoma; School grade

Indexed keywords

ANTINEOPLASTIC AGENT;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ARTICLE; AVERAGE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER THERAPY; CENTRAL NERVOUS SYSTEM; CHILD; CHILDHOOD; CHILDHOOD CANCER; CONTROLLED STUDY; EDUCATION; FEMALE; FINLAND; GENDER; HODGKIN DISEASE; HUMAN; LANGUAGE; LYMPHOMA; MALE; MATHEMATICS; NEOPLASM; NEPHROBLASTOMA; NONHODGKIN LYMPHOMA; PHYSICAL EDUCATION; POPULATION DYNAMICS; PRIORITY JOURNAL; CASE CONTROL STUDY; EDUCATIONAL STATUS; PSYCHOLOGICAL ASPECT; REGISTER;

ADOLESCENT; CASE-CONTROL STUDIES; EDUCATIONAL STATUS; FEMALE; FINLAND; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; REGISTRIES; WILMS TUMOR;

EID: 53449095759     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23753     Document Type: Article

References (35)

1. Mulhern RK, Butler RW. Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Rehabil 2004;7:1-15.
2. Mulhern RK, Wasserman AL, Friedman AG, Fairclough D. Social competence and behavioral adjustment of children who are long-term survivors of cancer. Pediatrics 1989;83:18-25.
3. Kelaghan J, Myers MH, Mulvihill JJ, Byrne J, Connelly RR, Austin DF, Strong LC, Meigs JW, Latourette HB, Holmes GF. Educational achievement of long-term survivors of childhood and adolescent cancer. Med Pediatr Oncol 1988;16:320-6.
4. Mitby PA, Robison LL, Whitton JA, Zevon MA, Gibbs IC, Tersak JM, Meadows AT, Stovall M, Zeltzer LK, Mertens AC, Childhood Cancer Survivor Study Steering Committee. Utilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the childhood cancer survivor study. Cancer 2003;97:1115-26.
5. Koch SV, Kejs AM, Engholm G, Johansen C, Schmiegelow K. Educational attainment among survivors of childhood cancer: a population-based cohort study in Denmark. Br J Cancer 2004;91:923-8.
6. Lähteenmäki PM, Harila-Saari A, Pukkala EI, Kyyrönen P, Salmi TT, Sankila R. Scholastic achievements of children with brain tumors at the end of comprehensive education: a nationwide, register-based study. Neurology 2007;69:296-305.
7. Lansky SB, Cairns NU, Lansky LL, Cairns GF, Stephenson L, Garin G. Central nervous system prophylaxis. Studies showing impairment in verbal skills and academic achievement. Am J Pediatr Hematol Oncol 1984;6:183-90.
8. Haupt R, Fears TR, Robison LL, Mills JL, Nicholson HS, Zeltzer LK, Meadows AT, Byrne J. Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. JAMA 1994;272:1427-32.
9. Kingma A, Rammeloo LA, van Der Does-van den Berg A, Rekers-Mombarg L, Postma A. Academic career after treatment for acute lymphoblastic leukemia. Arch Dis Child 2000;82:353-7.
10. Harila-Saari AH, Lähteenmäki PM, Pukkala E, Kyyrönen P, Lanning M, Sankila R. Scholastic achievements of childhood leukemia patients: a nationwide, register-based study. J Clin Oncol 2007;25:3518-24.
11. Langeveld NE, Ubbink MC, Last BF, Grootenhuis MA, Voute PA, De Haan RJ. Educational achievement, employment and living situation in long-term young adult survivors of childhood cancer in the Netherlands. Psychooncology 2003;12:213-25.
12. Langer T, Martus P, Ottensmeier H, Hertzberg H, Beck JD, Meier W. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory. Med Pediatr Oncol 2002;38:320-8.
13. Cousens P, Ungerer JA, Crawford JA, Stevens MM. Cognitive effects of childhood leukemia therapy: a case for four specific deficits. J Pediatr Psychol 1991;16:475-88.
14. Balis FM, Poplack DG. Central nervous system pharmacology of anti-leukemic drugs. Am J Pediatr Hematol Oncol 1989;11:74-86.
15. Barrera M, Shaw AK, Speechley KN, Maunsell E, Pogany L. Educational and social late effects of childhood cancer and related clinical, personal, and familial characteristics. Cancer 2005;104:1751-60.
16. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365-9.
17. Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D, Lutz P, Coze C, Perel Y, Raphael M, Terrier-Lacombe MJ, Societe Francaise d'Oncologie Pediatrique. The societe francaise d'oncologie pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 2001;97:3370-9.
18. Gustafsson G, Kreuger A, Clausen N, Garwicz S, Kristinsson J, Lie SO, Moe PJ, Perkkio M, Yssing M, Saarinen-Pihkala UM. Intensified treatment of acute childhood lymphoblastic leukemia has improved prognosis, especially in non-high-risk patients: The Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic society of pediatric hematology and oncology (NOPHO). Acta Paediatr 1998;87:1151-61.
19. Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, Mellander L, Makipernaa A, Nygaard R, Saarinen-Pihkala UM. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic society of pediatric hematology and oncology (NOPHO). Leukemia 2000;14:2267-75.
20. Weiner MA, Leventhal B, Brecher ML, Marcus RB, Cantor A, Gieser PW, Ternberg JL, Behm FG, Wharam MD, Jr, Chauvenet AR. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB. IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a pediatric oncology group study. J Clin Oncol 1997;15:2769-79.
21. Schellong G, Potter R, Bramswig J, Wagner W, Prott FJ, Dorffel W, Korholz D, Mann G, Rath B, Reiter A, Weissbach G, Riepenhausen M, et al. High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian pediatric Hodgkin's disease study group. J Clin Oncol 1999;17:3736-44.
22. D'Angio GJ. The national Wilms tumor study: a 40 year perspective. Lifetime Data Anal 2007;13:463-70.
23. Roman DD, Sperduto PW. Neuropsychological effects of cranial radiation: current knowledge and future directions. Int J Radiat Oncol Biol Phys 1995;31:983-98.
24. Hill JM, Kornblith AB, Jones D, Freeman A, Holland JF, Glicksman AS, Boyett JM, Lenherr B, Brecher ML, Dubowy R, Kung F, Maurer H, et al. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Cancer 1998;82:208-18.
25. Smibert E, Anderson V, Godber T, Ekert H. Risk factors for intellectual and educational sequelae of cranial irradiation in childhood acute lymphoblastic leukemia. Br J Cancer 1996;73:825-30.
26. Marky I, Bjork O, Forestier E, Jonsson OG, Perkkio M, Schmiegelow K, Storm-Mathiesen I, Gustafsson G, Nordic Society of Pediatric Hematology and Oncology. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the Nordic society of pediatric hematology and oncology. J Pediatr Hematol Oncol 2004;26:555-60.
27. Carey ME, Hockenberry MJ, Moore IM, Hutter JJ, Krull KR, Pasvogel A, Kaemingk KL. Brief report: effect of intravenous methotrexate dose and infusion rate on neuropsychological function one year after diagnosis of acute lymphoblastic leukemia. J Pediatr Psychol 2007;32:189-93.
28. Barr RD, Chalmers D, De Pauw S, Furlong W, Weitzman S, Feeny D. Health-related quality of life in survivors of Wilms' tumor and advanced neuroblastoma: a cross-sectional study. J Clin Oncol 2000;18:3280-7.
29. Bradley WG, Lassman LP, Pearce GW, Walton JN. The neuromyopathy of vincristine in man. clinical, electrophysiological and pathological studies. J Neurol Sci 1970;10:107-31.
30. Weiden PL, Wright SE. Vincristine neurotoxicity. N Engl J Med 1972;286:1369-70.
31. Makipernaa A, Heikkila JT, Merikanto J, Marttinen E, Siimes MA. Spinal deformity induced by radiotherapy for solid tumors in childhood: a long-term follow up study. Eur J Pediatr 1993;152:197-200.
32. Paulino AC, Wen BC, Brown CK, Tannous R, Mayr NA, Zhen WK, Weidner GJ, Hussey DH. Late effects in children treated with radiation therapy for Wilms' tumor. Int J Radiat Oncol Biol Phys 2000;46:1239-46.
33. Meacham LR, Gurney JG, Mertens AC, Ness KK, Sklar CA, Robison LL, Oeffinger KC. Body mass index in long-term adult survivors of childhood cancer: a report of the childhood cancer survivor study. Cancer 2005;103:1730-9.
34. Twaddle V, Britton PG, Kernahan J, Craft AW. Intellect after malignancy. Arch Dis Child 1986;61:700-2.
35. PISA 2006 science competencies for tomorrow's world. Paris, France: OECD, 2007. 383 p.